Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Florence Joly Lobbedez"'
Autor:
Gilles Freyer, Jean Emmanuel Kurtz, Guelten Oskay-Oezcelik, Raymond Despax, Michel Fabbro, Dominique Berton-Rigaud, Elsa Kalbacher, Idlir Licaj, Marie Christine Kaminsky-Forrett, N. Dohollou, Alain Lortholary, Jalid Sehouli, Anne Floquet, Florence Joly Lobbedez, Nicolas Gane, Rémy Largillier, Marianne Lorcet, Pierre Combe, Isabelle Ray-Coquard, Thibault De La Motte Rouge, Anne Claire Hardy Bessard
Publikováno v:
Bulletin du Cancer. 105:465-474
Resume Introduction Expression IV est une enquete europeenne evaluant les attentes des patientes suivies pour un cancer de l’ovaire concernant les traitements d’entretien. Methode Quatre cent une patientes francaises ont repondu a un questionnair
Autor:
Marianne, Lorcet, Alain, Lortholary, Jean Emmanuel, Kurtz, Dominique, Berton-Rigaud, Michel, Fabbro, Thibault, De La Motte Rouge, Marie Christine, Kaminsky-Forrett, Anne, Floquet, Gilles, Freyer, Pierre, Combe, Nadine, Dohollou, Elsa, Kalbacher, Raymond, Despax, Remy, Largillier, Anne Claire, Hardy Bessard, Nicolas, Gane, Jalid, Sehouli, Guelten, Oskay-Oezcelik, Idlir, Licaj, Isabelle, Ray-Coquard, Florence, Joly Lobbedez
Publikováno v:
Bulletin du cancer. 105(5)
Expression IV survey evaluated the patients' expectations to a maintenance therapy.From January 2015 to March 2016, 401 French patients, in first line or recurrent disease, answered a 24-items anonymous questionnaire. The results were specifically an
Autor:
Todd Riehl, Martina Makrutzki, Noopur Raje, Vivek Subbiah, Antoine Hollebecque, David M. Hyman, Jordi Rodon Ahnert, Bethany Pitcher, Ian Chau, A. Craig Lockhart, Igor Puzanov, Juergen Wolf, Florence Joly Lobbedez, Thomas Kaley, Ralf Hofheinz, Jean-Yves Blay, José Baselga, Vicki L. Keedy
Publikováno v:
Journal of Clinical Oncology. 35:2004-2004
2004 Background: Recurrent malignant gliomas (MG) are a universally fatal disease in desperate need of better therapies. Pleiomorphic xanthoastrocytomas (PXA) and juvenile pilocytic astrocytomas (JPA) typically have better outcomes, although when rec
Autor:
Hannelore Denys, Anne Floquet, Frédéric Kridelka, Bahriye Aktas, Gunnar B. Kristensen, Jens Huober, Johanna Mäenpää, Christina Jederud, Trine Juhler-Nøttrup, Jean-François Baurain, Ignace Vergote, Per Rosenberg, Florence Joly Lobbedez, Philippe Follana, Toralf Reimer, Elena Ioana Braicu, Mansoor Raza Mirza, Dominique Berton-Rigaud, Jalid Sehouli, Anja Ør Knudsen
Publikováno v:
Journal of Clinical Oncology. 35:TPS5611-TPS5611
TPS5611 Background: Endometrial cancer (EC) patients with advanced and recurrent disease relapse despite treatment with combination chemotherapy and have a short progression-free survival (PFS). With the emerging clinical data on anti-angiogenic agen
Autor:
C. Lefeuvre-Plesse, Veronique Girre, Nadine Houede, Carole Helissey, Alain Zannetti, Laurence Vanlemmens, Jean-Marc Descotes, Laetitia Stefani, Bénédicte Mastroianni, S Bastien Salas, Florence Joly Lobbedez, Nathalie Meneveau, Claire Garnier-Tixidre, Valérie Plence, Claude Boiron, Franck Bonnetain, Sophie Abadie-Lacourtoisie, Stéphane Oudard, Frank Priou, Ivan Krakowski
Publikováno v:
Journal of Clinical Oncology. 35:TPS10126-TPS10126
TPS10126 Background: Fatigue is a frequent side effect with oral targeted therapies (OTT). Physical activity has been reported to improve fatigue and quality of life (QoL). However, few studies focused on metastatic cancer patients and mainly among p
Autor:
Sylvie Chevret, Emmanuel Sevin, Stéphane Oudard, Florence Joly Lobbedez, Christophe Massard, Antoine Thiery-Vuillemin, Safae Terrisse, Guillaume Mouillet, Jean-Marc Tourani, Guilhem Roubaud, Christine Theodore, Aude Flechon, Katharina Breitkopf, Stéphane Culine, Damien Pouessel
Publikováno v:
Journal of Clinical Oncology. 33:e16094-e16094
e16094 Background: C has been developed and approved for patients with progressive mCRPC after or during D chemotherapy. No efficacy data are available concerning the use of D or NGH after C delive...
Autor:
Thomas Schmelter, Patricia Pautier, Jörg Pinkert, Jean-François Baurain, Dominique Berton-Rigaud, Arnulf Stenzl, Mario Campone, Frederic Rolland, Marjan van Dijk, Natasja de Bont, Florence Joly-Lobbedez, Michel Fabbro
Publikováno v:
The Oncologist, Vol. 18, no.11, p. 1190-1191 (2013)
Background. Peripheral neuropathy (PN) is a recognized side effect of microtubule-targeting agents and the most clinically relevant toxicity observed with the epothilone sagopilone (SAG). Studies suggest that acetyl-L-carnitine (ALC) may prevent chem
Autor:
Dos Santos, Mélanie
Publikováno v:
Médecine humaine et pathologie. Normandie Université, 2021. Français. ⟨NNT : 2021NORMC420⟩
Cancer-related cognitive impairment is frequently reported by patients and can have an impact on quality of life, but also autonomy and adherence. Elderly patients appear to be particularly at risk for cognitive decline. Although the management of co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1398::54f41c6df62171fbb6e47ff628a0a555
https://tel.archives-ouvertes.fr/tel-03509188/file/sygal_fusion_28636-dos_santos-melanie_61c047d8c3a72.pdf
https://tel.archives-ouvertes.fr/tel-03509188/file/sygal_fusion_28636-dos_santos-melanie_61c047d8c3a72.pdf